pfizer

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1959-2017
05101519592017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Pfizer has failed in its bid to overturn a High Court ruling on the validity of the patents covering its painkiller pregabalin… (More)
Is this relevant?
2012
2012
An unprecedented amount of parallel synthesis information was accumulated within Pfizer over the past 12 years. This information… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2012
Review
2012
BACKGROUND Elevated cardiometabolic morbidity and mortality in patients with schizophrenia and bipolar disorder have been… (More)
Is this relevant?
2011
2011
Shock waves continue to reverberate around the RNA interference (RNAi) commercial sector following announcements last year from… (More)
  • table 1
Is this relevant?
Review
2011
Review
2011
It was less than two years ago that the pharmaceutical giant Pfizer made headlines when it acquired the drugmaker Wyeth for a… (More)
Is this relevant?
2011
2011
299 Pfizer is by no means alone in axing research jobs, however. Economizing on internal R&D spending is “an escalating trend… (More)
  • table 1
Is this relevant?
2007
2007
After 11 years of development and barely one full year of sales, New York–based Pfizer dumped the much-anticipated inhaled powder… (More)
Is this relevant?
Review
2005
Review
2005
  • L Gennari
  • Current opinion in investigational drugs
  • 2005
Pfizer is developing lasofoxifene, an oral naphthalene derivative selective estrogen receptor modulator identified under a… (More)
Is this relevant?
2004
2004
BACKGROUND Sildenafil (Pfizer Pharmaceuticals, Sandwich, Kent, UK) has been associated with pulmonary vasorelaxation. A more… (More)
Is this relevant?
1999
1999
in Europe: EPO receives only 100 patent claims on transgenic plants out of 120,000 total patent applications every year… (More)
Is this relevant?